Hypertension after renal transplantation

Journal of Human Hypertension

Volumn 18, Issue 12, 2004, Pages 835-836

  Textor, Stephen C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NIFEDIPINE; STEROID; TACROLIMUS;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CIRCADIAN RHYTHM; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG PREFERENCE; DRUG SAFETY; ENDOTHELIUM LESION; FIBROSING ALVEOLITIS; GRAFT SURVIVAL; HEMOLYSIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MICROANGIOPATHY; NOTE; PROTEINURIA; RENOVASCULAR DISEASE; SIDE EFFECT; SODIUM RETENTION; VASOCONSTRICTION;

CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION;

EID: 10044292917     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001766     Document Type: Note

References (12)

1. Pascual M et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002; 346 580-590.
2. Cosio FG et al. Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology. Kidney Int 2000; 56: 1912-1919.
3. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-638.
4. Textor SC et al. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transplant 2000; 6: 521-530.
5. Textor SC et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int 1995; 47: 1426-1433.
6. Nankivell BJ et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
7. Neumayer HH, Kunzendorf U, Schreiber M. Protective effects of calcium antagonists in human renal transplantation. Kidney Int 1992; 41(Suppl 36): 87s-93s.
8. Palmer BF et al. Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation 1991; 52: 640-645.
9. Mehrens T et al. The beneficial effects of calcium channel blockers on long-term kidney transplant survival are independent of blood pressure reduction. Clin Transplant 2000; 14: 257-261.
10. Premasathian NC et al. Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens 2004; 99: 9999.
11. Mange KC et al. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol 2004; 15 187-193.
12. Textor SC et al. Systemic and renal effects of nifedipine in cyclosporine-associated hypertension. Hypertension 1994; 23(Suppl I): I-220-I-224.